Silver Book

Silver Book Fact

Aortic valve disease costs

Aortic valve disease (AVD) (symptomatic and asymptomatic) costs the U.S. $10.2 billion in direct costs each year.

Moore M, Chen J, Mallow P, Rizzo J. The Direct Health-Care Burden of Valvular Heart Disease: Evidence from US national survey data. Clinicoecon Outcomes Res. 2016; 8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5076539/pdf/ceor-8-613.pdf

Reference

Title
The Direct Health-Care Burden of Valvular Heart Disease: Evidence from US national survey data
Publication
Clinicoecon Outcomes Res
Publication Date
2016
Authors
Moore M, Chen J, Mallow P, Rizzo J
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Publications

Aortic Stenosis Fact Sheet

 https://www.silverbook.org/wp-content/uploads/2017/10/AS-FS-cover.png Thumbnail

Connected Facts

Valve Disease

The annual total incremental per patient health care expenditures for heart valve disease patients ranged from $1,755 in 1996 to $12,789 in 2011.
Economic Burden

Aortic Stenosis

Projections of Significant Heart Valve Disease — Diagnosed & Undiagnosed — in the 65+ U.K. Population

Future Economic Burden

Aortic Stenosis

Five-year health care resource use in medically managed SAS patients

Economic Burden

Aortic Stenosis

Mean 5-Year Cumulative Total Medical Costs Per Medically Managed (No AVR) Severe AS Patient

Economic Burden

Aortic Stenosis

SAS patient hospitalization costs

Symptomatic aortic stenosis (SAS) patients who do not undergo treatment cost Medicare as much as $1.3 billion each year due to rehospitalization, prolonged stays, admissions to skilled nursing facilities, and use of hospice care.

Economic Burden

Aortic Stenosis

Survival Rates Over 5 Years for Patients with Medically Managed Severe Aortic Stenosis

Human Burden

Aortic Stenosis

Increased hospital admissions and prolonged length of stay for patients who do not undergo treatment

Medicare severe symptomatic aortic stenosis (sSAS) patients who do not undergo treatment have an average of 1.9 hospital admissions per year and prolonged lengths of stay — 11.5 hospital days per patient-year.

Human Burden

Aortic Stenosis

All-cause mortality for aortic valve disorders

In 2014, all-cause mortality for aortic valve disorders was 34,408 in the U.S.

Human Burden

Aortic Stenosis

1 and 6-month mortality rates without treatment for sSAS

Waiting for treatment for severe symptomatic aortic stenosis (sSAS) can be deadly, with 1-month mortality at 3.7% and 6-month mortality at 11.6% (measured from the time intervention was recommended).

Human Burden

Aortic Stenosis

Lifespan of Medicare patients with sSAS who do not undergo treatment

Medicare patients with severe symptomatic aortic stenosis (sSAS) who do not undergo treatment have an average lifespan of 1.8 years.

Human Burden

Related Facts

  • Moderate or severe aortic valve disease is present in 4.2% to 10.7% of the population ages 65 and older.
     
  • Mean 5-Year Cumulative Total Medical Costs Per Medically Managed (No AVR) Severe AS Patient
     
  • SAS patient hospitalization costs
    Symptomatic aortic stenosis (SAS) patients who do not undergo treatment cost Medicare as much as $1.3 billion each year due to rehospitalization, prolonged stays, admissions to skilled nursing facilities, and…  
  • Projections of Significant Heart Valve Disease — Diagnosed & Undiagnosed — in the 65+ U.K. Population
     
  • 2016 prevalence of Americans 65+ who had AVD
    In 2016, an estimated 5.2 million U.S. adults ages 65+ had aortic valve disease (AVD).   Note: Alliance for Aging Research generated statistic, based on 2005 percentage prevalence estimates by Bach et al. 2007